In the News

Alzheimer’s Research and Treatment Center

Alzheimer’s Research and Treatment Center integral in getting approval of new treatment.

On Friday, Jan. 6, 2023, Lecanemab, a treatment for mild cognitive impairment due to Alzheimer’s Disease and mild Alzheimer’s Disease, was approved for use by the Food and Drug Administration.

Alzheimer’s Research and Treatment Center integral in getting approval of new treatment.

On Friday, Jan. 6, 2023, Lecanemab, a treatment for mild cognitive impairment due to Alzheimer’s Disease and mild Alzheimer’s Disease, was approved for use by the Food and Drug Administration.

Lecanemab FDA Approval.

Lecanemab FDA Approval.

Dr. Watson, the world’s leading investigator for the Lecanemab compound, letter and statement on the FDA approval of Lecanemab. We are all ecstatic here at ARTC with the approval of the Lecanemab. This is the first disease modifying treatment to be approved anywhere in the world. This approval...

read more
Lecanemab in Early Alzheimer’s Disease.

Lecanemab in Early Alzheimer’s Disease.

Dr. David Watson of ARTC is one of the primary author's of this article on Lecanemab and Alzheimer's Disease. The accumulation of soluble and insoluble aggregated amyloid-beta (Aβ) may initiate or potentiate pathologic processes in Alzheimer’s disease. Lecanemab, a humanized IgG1 monoclonal...

read more

Nationally Recognized Treatment Center located in the heart of Palm Beach and Martin counties.

 

 

Wellington Location

2767 S. State Road 7, Suite 300
Wellington, FL 33414

(561) 209-2401

Stuart Location

1111 SE Indian Street, Suite 102
Stuart, FL 34997

(772) 675-1111